Conmed Corp (CNMD) returns
Conmed returns over 10 years
$1,000 invested in Conmed ten years ago was worth $1,217 at the close on October 30, 2026, with dividends reinvested: an average return of 2.0% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -4.2% | — | $958.04 | -0.9% |
| 3 months | -5.7% | — | $942.74 | +2.1% |
| Year to date | +9.1% | — | $1,091 | +11.7% |
| 1 year | -0.4% | — | $995.51 | +12.4% |
| 3 years | -53.5% | -22.5% | $464.80 | +88.5% |
| 5 years | -68.5% | -20.6% | $314.72 | +76.0% |
| 10 years | +21.7% | +2.0% | $1,217 | +316.6% |
Conmed return by calendar year
| Year | CNMD | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +9.1% | +11.7% | -2.6% |
| 2025 | -40.0% | +17.7% | -57.7% |
| 2024 | -36.8% | +24.9% | -61.7% |
| 2023 | +24.4% | +26.2% | -1.7% |
| 2022 | -37.0% | -18.2% | -18.8% |
| 2021 | +27.4% | +28.7% | -1.4% |
| 2020 | +1.1% | +18.4% | -17.2% |
| 2019 | +75.7% | +31.2% | +44.5% |
| 2018 | +27.4% | -4.6% | +31.9% |
| 2017 | +17.3% | +21.7% | -4.4% |
| 2016 | +2.2% | +12.0% | -9.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: CNMD financials · CNMD valuation
No forecast, no recommendation. This page describes Conmed Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.